|
Volumn 311, Issue 2, 2001, Pages 91-94
|
Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients
|
Author keywords
Antioxidant vitamins; Atorvastatin; LDL oxidation; Type 2 diabetes
|
Indexed keywords
ALKADIENE;
ALPHA TOCOPHEROL;
ANTIDIABETIC AGENT;
ANTIOXIDANT;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN B;
ATORVASTATIN;
COPPER;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
INSULIN;
LOW DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
UBIQUINOL;
UBIQUINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ARTICLE;
BLOOD ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HUMAN;
LIPID BLOOD LEVEL;
LIPID PEROXIDATION;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OXIDATION;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VITAMIN BLOOD LEVEL;
AGED;
ANTICHOLESTEREMIC AGENTS;
ANTIOXIDANTS;
BLOOD GLUCOSE;
CHOLESTEROL, LDL;
DIABETES MELLITUS, TYPE 2;
DOUBLE-BLIND METHOD;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HEPTANOIC ACIDS;
HUMANS;
LIPIDS;
MALE;
MIDDLE AGED;
OXIDATION-REDUCTION;
PYRROLES;
UBIQUINONE;
VITAMIN E;
|
EID: 0035949749
PISSN: 00098981
EISSN: None
Source Type: Journal
DOI: 10.1016/S0009-8981(01)00549-6 Document Type: Article |
Times cited : (36)
|
References (12)
|